Genital Chlamydia trachomatis infections in patients with cervical atypia.
Of 177 gynecologic outpatients with cervical dysplasia studied, 29 (16%) were found to excrete Chlamydia trachomatis from their urogenital tract. Sera collected from 93 of these patients were significantly more often positive for and showed higher levels of antichlamydial micro-complement fixation (CF) and immunofluorescence (IF) antibodies than sera obtained from the controls. However, when the sera were tested for anti-herpesvirus type II (HSV-II) and cytomegalovirus (CMV) antibodies, no difference between the cases and the controls were encountered.
D000293:Adolescent; D000328:Adult; D000907:Antibodies, Bacterial / Q000032:analysis; D000914:Antibodies, Viral / Q000032:analysis; D002690:Chlamydia Infections / Q000150:complications / Q000453:epidemiology* / Q000276:immunology; D002692:Chlamydia trachomatis / Q000276:immunology; D003587:Cytomegalovirus / Q000276:immunology; D005260:Female; D005831:Genital Diseases, Female / Q000150:complications / Q000453:epidemiology* / Q000276:immunology; D006801:Humans; D008875:Middle Aged; D011446:Prospective Studies; D018139:Simplexvirus / Q000276:immunology; D002578:Uterine Cervical Dysplasia / Q000150:complications* / Q000276:immunology; D002583:Uterine Cervical Neoplasms / Q000150:complications*
D000907:Antibodies, Bacterial; D000914:Antibodies, Viral